1.	Total Thyroidectomy With Harmonic Scalpel® Phase: Phase IV Type: Health services research, Treatment Status: Approved-not yet active Age: Over 18 Sponsor: Other Protocol IDs: CP005, NCT00385983
2.	Fosbretabulin or Placebo in Combination With Carboplatin/Paclitaxel in Anaplastic Thyroid Cancer Phase: Phase III Type: Treatment Status: Approved-not yet active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: OX4317s, NCT01701349
3.	A Phase I/II Trial of Crolibulin (EPC2407) Plus Cisplatin in Adults With Solid Tumors With a Focus on Anaplastic Thyroid Cancer (ATC) Phase: Phase II, Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 to 90 Sponsor: NCI Protocol IDs: 110027, 11-C-0027, NCT01240590
4.	Pazopanib Hydrochloride in Treating Patients With Advanced Thyroid Cancer Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: NCI-2009-00198, MC057H, CDR0000588044, N01CM00099, MAYO-MC057H, 7627, NCT00625846
5.	Pemetrexed + Paclitaxel in Patients With Recurrent/Advanced Thyroid Cancer Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: Panthera, NCT00786552
6.	RAD001 for Patients With Radioiodine Refractory Thyroid Cancer Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 09-049, NCT00936858
7.	Everolimus in Treating Patients With Progressive or Recurrent, Unresectable, or Metastatic Thyroid Cancer. Note: The information about this trial has not been updated by the sponsor/principal investigator/lead organization. Cancer.gov cannot verify the accuracy of the information. Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: DUT-LUMC-CRAD001CNL08T, LUMC-CRAD001CNL08T, EUDRACT-2009-016669-27, EU-21037, NL-31245-058-10, THYRRAD, NCT01118065
8.	Everolimus in Treating Patients With Locally Advanced or Metastatic Thyroid Cancer Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 4-2009-0542, YONSEI-CRAD001CKR12T, KCSG-HN-10-03, CRAD001CKR12T, NCT01164176
9.	Intensity-Modulated Radiation Therapy and Paclitaxel With or Without Pazopanib Hydrochloride in Treating Patients With Anaplastic Thyroid Cancer Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: NCI-2011-02614, RTOG-0912, U10CA021661, CDR0000688092, NCT01236547
10.	Tumor Metabolism of Head and Neck Cancer in Patients Who Underwent Radiation Therapy Measured With F-18-FDG-PET Phase: No phase specified Type: Natural history/Epidemiology, Treatment Status: Active Age: 18 to 70 Sponsor: Other Protocol IDs: HNO-FDG-FU, NCT00180245
11.	Iodine I 131 in Treating Patients With Thyroid Cancer Phase: No phase specified Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 to 100 Sponsor: NCI, Other Protocol IDs: CDR0000522716, JHOC-J0628, NCT00416949